Table 3.
Cox univariate analysis for 5-year survival in 103 patients
| |
5-Year overall survival |
5-Year disease-free survival |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Hemoglobin (non-anemic vs anemic) |
1.799 |
1.123-2.882 |
0.015 |
1.946 |
1.217-3.112 |
0.005 |
| Tumor location (C vs U vs M vs L) |
0.945 |
0.739-1.208 |
0.650 |
0.935 |
0.729-1.199 |
0.595 |
| Treatment modality (RT vs S + RT vs CRT vs S + CRT) |
0.856 |
0.681-1.076 |
0.183 |
0.916 |
0.741-1.133 |
0.420 |
| TNM stage (I vs II vs III vs IV) |
1.732 |
1.240-2.418 |
0.001 |
1.783 |
1.263-2.518 |
0.001 |
| T stage (T1 vs T2 vs T3 vs T4) |
1.319 |
0.988-1.761 |
0.060 |
1.441 |
1.071-1.939 |
0.016 |
| Status of lymph node (negative vs positive) | 2.216 | 1.394-3.523 | 0.001 | 1.769 | 1.127-2.776 | 0.013 |
C, cervical; CRT, chemoradiotherapy; HR, hazard ratio; L, low; M, middle; RT, radiotherapy; S, surgery; U, upper.